Navigation Links
Talyst Moves Patient Safety and Inventory Control Beyond the Hospital
Date:12/7/2008

BELLEVUE, Wash., Dec. 7 /PRNewswire/ -- Talyst, a leader in pharmacy automation, today demonstrated InSite(TM), its innovative hardware and software system designed to help central pharmacies provide unparalleled support for extended care environments with the use of remote dispensing technologies. The products were developed in response to hospital pharmacies' increasing need to implement safer, more cost-effective ways to service the long-term care and correctional care environments they support.

InSite is being demonstrated this week at the American Society of Health-System Pharmacist (ASHP) Midyear Clinical Meeting in Orlando, FL.

"Talyst is committed to engineering a safer pharmacy in all healthcare environments. We have a strong history of delivering innovative automation solutions to our hospital pharmacy customers, and InSite is a natural extension of that innovation," noted Carla Corkern, chief executive officer of the company. "Talyst was the first to provide inventory and workflow management control to all medication inventory locations, including support for multiple hospitals. With Talyst InSite, we are the first to extend that control to extended care environments managed by the hospital or integrated delivery network."

A New Model for Remote Medication Management

The InSite Remote Dispensing System allows the central pharmacy to place a secure, automated medication dispensing unit at each facility they service. With InSite, medications are already at the facility and pharmacist-approved medication orders are immediately available for dispensing in patient-specific, multi-dose packaging.

The innovative InSite system helps eliminate the need to create time-consuming, waste-prone medication blister packs. It also enables faster First Doses, gives nursing staff more time for other tasks, and allows down-to-the-dose accountability at each facility.

With centralized inventory monitoring, InSite requires far fewer scheduled deliveries and special courier runs from the central pharmacy in order to meet the changing needs of the facilities.

"Healthcare system pharmacies are increasingly looking for ways to improve the safety and efficiency of their pharmacy operations beyond the traditional in-patient settings," Corkern continued. "In a challenging economy, a growing number of hospital pharmacies are being asked to improve cost controls and find new revenue sources. The InSite system improves the partnership between central pharmacies and the facilities they support, and enables new opportunities for growth and safety improvements," she concluded.

About Talyst

Talyst is engineering a safer pharmacy. The company provides automated systems to hospitals, long-term care facilities and correctional facilities to improve patient safety and dispensing accuracy while reducing costs and increasing productivity. The Talyst solution uses innovative software and a suite of proven hardware components to package, barcode, store and track medication inventories.

Talyst is an award-winning company with more than 300 hospital and integrated healthcare companies. The company is ranked in the "Inc. 500" national list of fastest-growing private companies, ranked number two on the Deloitte "Fast 50" Technology Companies in Washington State, and was listed as one of Fast Company magazine's "Fast 50 Reader Favorites", honoring innovative, progressive enterprises.

For more information, call 877-4-Talyst (877-482-5978) or visit www.talyst.com, www.talyst.com/ltc or see www.talyst.com/corrections.

Talyst and InSite are trademarks of Talyst Inc. Other trade names are the property of their respective owners.


'/>"/>
SOURCE Talyst
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Talyst Unveils InSite for Long-Term Care
2. Catalyst Biosciences Appoints Dr. Todd Lorenz Chief Medical Officer
3. Catalyst mystery unlocked
4. CATalyst Council Forms to Address Feline Health Care
5. Congress Approves ePrescribing Initiative in Medicare Reform Bill: Critical Catalyst in Driving a New Generation of Prescribing
6. Catalyst Pharmaceutical Partners, Inc. Set to Join Russell Microcap(R) Index
7. Case in Point: Patient Control of Data Critical Catalyst for Online Health Care Revolution
8. Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance
9. Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the Investment in Innovation (In3) West Conference on February 29, 2008 in Las Vegas, NV
10. CATalyst Summit Declared a Success: Its All About the Cat!
11. Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, ... University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) ... program, developed in association with efforts by the American College of Surgeons, U.S. ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... laboratory instruments are critical to ensuring high-quality results and maintaining GMP and USP ... of Laboratory Instruments in accordance with GMP requirements " these requirements are explained. ...
(Date:3/28/2017)... ... 28, 2017 , ... With less than 10,000 dermatologists in the United States ... be limited while the desire to conquer breakouts and eliminate skincare stress is widespread. ... customer online, today released its inaugural survey on the State of Acne in America. ...
(Date:3/28/2017)... ... , ... Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics in Ohio ... country to sit on the 2017 National Advisory Board for Allergan’s Facial Aesthetics National ... helped propel the clinic from a small start-up to number 78 in the country ...
(Date:3/28/2017)... ... March 28, 2017 , ... Public relations pros work hard to ... of business channels. , While many results are clear, much of PR is hard ... , When it comes to measurement, firms should always take an all-inclusive approach that ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
(Date:3/28/2017)... , March 28, 2017 ... research with Cambridge ... Consortium   The Milner Therapeutics Institute today announces ... Elysium Health has committed significant investment for collaborative projects with ... next four years. This is the first major research investment ...
(Date:3/27/2017)... TEL-AVIV, Israel , March 27, 2017 /PRNewswire/ ... TASE: THXBY), a specialty clinical-stage pharmaceutical company specializing in the ... of its public offering in the ... Shares (ADSs), each ADS representing 40 ordinary shares ... per ADS. In addition, Therapix has granted the ...
Breaking Medicine Technology: